Evidence map›Paper›PMID 34377628›Full record

ReviewCurrent pharmacology reports2021

Evaluation of the Pharmacologic Treatment of COVID-19 Pandemic in Iraq.

Omeed Darweesh, Ghayth M Abdulrazzaq, Radhwan N Al-Zidan, Pshtiwan Bebane, Marwan Merkhan, Ruya Aldabbagh, Nohad AlOmari

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Current pharmacology reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Omeed DarweeshCollege of Pharmacy, Al-kitab University, Kirkuk, Iraq.
Ghayth M AbdulrazzaqCollege of Pharmacy, University of Mosul, Mosul, Iraq.
Radhwan N Al-ZidanCollege of Pharmacy, University of Mosul, Mosul, Iraq.ORCID https://orcid.org/0000-0003-2067-4531
Pshtiwan BebaneCollege of Education, Charmo University, Chamchamal, Iraq.
Marwan MerkhanCollege of Pharmacy, Ninevah University, Mosul, Iraq.
Ruya AldabbaghKirkuk Health Directorate, Ministry of Health, Kirkuk, Iraq.
Nohad AlOmariCollege of Pharmacy, Knowledge university, Erbil, Iraq.ORCID 0000-0002-4373-2776
University of Mosul · IQUniversity of Kirkuk · IQCharmo University

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, or COVID-19) has been detrimental to human health, economy, and wellbeing. Little information is known on the epidemiology and outcome of the disease in a localized community within Iraq. We carried out an audit of confirmed cases of COVID-19 in the Kirkuk General Hospital. Data from the 20th of June to the 31st of July, 2020, were collected and analyzed. Suspected COVID-19 cases were confirmed by real-time polymerase chain reaction (RT-PCR). Data on clinical symptoms, age, and treatment protocols were analyzed concerning the outcome. Our study included a total of 200 individual confirmed COVID-19 patients. The majority of cases 55% (

Indexed as

Clinical featuresCOVID-19Hospitalization stayMortalityTreatment strategies

Identifiers

PMID34377628
PMCPMC8339216
OpenAlexW3188721527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.